Skip to content

Regulatory effect of Lihuo probiotics on intestinal flora imbalance in patients with acute pancreatitis and its relationship with clinical prognosis: a randomized, double-blind, placebo-controlled study

Regulatory effect of Lihuo probiotics on intestinal flora imbalance in patients with acute pancreatitis and its relationship with clinical prognosis: a randomized, double-blind, placebo-controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052968
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Probiotic group:Take probiotics: 1 bag at a time, twice a day for 4 weeks
Placebo group:Take placebo: 1 bag at a time, twice a day for 4 weeks

Sponsors

The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients predicted to be moderately severe acute pancreatitis, SIRS score >=2 points, or Marshall score >=2 points, or APACHII score >=8 points; 2. Within 48 hours of onset; 3. Aged 18-75 years; 4. Willing to abide by the research procedures and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Two or more organ failures within 48 hours of onset; 2. Application of probiotics or antibiotics in the past 1 month; 3. Diabetes, liver cirrhosis, malignant tumor, autoimmune disease; 4. Pregnant and lactating women; 5. Combined with gastrointestinal bleeding; 6. Combined with gastrointestinal fistula.

Design outcomes

Primary

MeasureTime frame
Incidence of flora disorder index returning to normal (refers to a 20% decrease in flora disorder index);

Secondary

MeasureTime frame
Related indexes of intestinal function;Related indicators of complications and outcome;

Countries

China

Contacts

Public ContactZhu Yin

The First Affiliated Hospital of Nanchang University

zhuyin27@sina.com+86 13970841464

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026